Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02031783
Other study ID # 13.09.PER
Secondary ID
Status Completed
Phase N/A
First received November 26, 2013
Last updated July 8, 2014
Start date November 2013
Est. completion date January 2014

Study information

Verified date July 2014
Source Nestlé
Contact n/a
Is FDA regulated No
Health authority New Zealand: Ethics Committee
Study type Interventional

Clinical Trial Summary

The primary objective is to show that multiple transportable carbohydrate ingestion is more effective in improving endurance performance compared to single transportable carbohydrate ingestion.


Recruitment information / eligibility

Status Completed
Enrollment 74
Est. completion date January 2014
Est. primary completion date January 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

- Males aged 18 to 60 years

- A history of competitive triathlon performance (= 2 years)

- Participation in at least four competitive triathlon events within the past 2 years

- Be in regular training for triathlon events

- A personal best time for a standard ½ Ironman race (1.9 km swim, 90 km cycle, 21.1 km run) in the last year of either:

- = 6 h 00 min, for men aged 18-40 years

- or =6 h 05 min for men aged 40-50 years

- or =6 h 20 min for men aged 50-60 years

- Alternatively, if not competed in ½ Ironman in the last year, at least one standard distance triathlon (1.5 km swim, 40 km cycle, 10 km run) within the last 12 months:

- =2 h 13 min, for men aged 18-40 years

- or =2 h 18 min for men aged 40-50 years

- or =2 h 23 min for men aged 50-60 years

- Available to compete in the ½ Ironman events and complete all study requirements

- Experienced in using carbohydrate supplementation, as gels, bars, and drinks in training/racing, specifically at rates =60-90g/h)

- Experience of specific formulations may include both or only multiple and single transportable carbohydrates, thus a full assessment would be made prior to recruitment to ensure balance during randomization and account for any association with the primary outcome

- Obtained his (or his legal representative's) informed consent.

Exclusion Criteria:

- Failure to meet health requirements defined in the Health Questionnaire

- Prior known fructose intolerance

- Wheat intolerance or other precluding food or packaging-related allergies

- An existing injury affecting ability to race to best ability

- A chronic injury that may affect ability to complete the races

- Unable to carry out performance assessments and questionnaires correctly

- Unable to tolerate the treatment during the familiarization sessions

- Taking medications thought to interfere with the study outcomes

- Currently participating or having participated in another clinical study during the last four weeks prior to the beginning of this study

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Mixture of glucose and fructose

glucose


Locations

Country Name City State
New Zealand Massey University Wellington

Sponsors (1)

Lead Sponsor Collaborator
Nestlé

Country where clinical trial is conducted

New Zealand, 

Outcome

Type Measure Description Time frame Safety issue
Primary TIME to finish a long distance triathlon Total time recorded at the end of the race 1 and race 2 No
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1